Inventor · disambiguated record
Daniel H. Byun
Also filed as: BYUN DANIEL · BYUN DANIEL H
23 granted patents·6 pending applications·76 citations·filing 2010–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0197US11939347B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Mar 26, 2024·7 cites·45 claims
- 0297US11851438B21′-cyano nucleoside analogs and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Dec 26, 2023·9 cites·16 claims
- 0397US11845755B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Dec 19, 2023·7 cites·16 claims
- 0497US11780844B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Oct 10, 2023·7 cites·6 claims
- 0596US12180217B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Granted Dec 31, 2024·3 cites·12 claims
- 0695US11878965B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Jan 23, 2024·4 cites·20 claims
- 0792US9394275B2Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 0891US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 0991US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 1091US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 1190US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 1290US2025197410A1Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1389US12448383B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Oct 21, 2025·0 cites·10 claims
- 1489US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 1584US2023295172A1Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1681US12404289B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 1781US10138220B1Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Nov 27, 2018·1 cites·26 claims
- 1876US2025002513A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1976US2021024493A1Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist ActivityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Application pending·0 cites
- 2074US10836744B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Granted Nov 17, 2020·0 cites·22 claims
- 2174US10590107B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2019·Granted Mar 17, 2020·0 cites·26 claims
- 2274US2023295201A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2372US10358433B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Jul 23, 2019·0 cites·26 claims
- 2466US11718637B2Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the sameGILEAD SCIENCES INC·Filed 2021·Granted Aug 8, 2023·0 cites·34 claims
- 2564US12410160B2KHK inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Sep 9, 2025·0 cites·38 claims
- 2663US12030903B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 9, 2024·0 cites·33 claims
- 2761US2022356196A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2858US12240862B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Mar 4, 2025·0 cites·12 claims
- 2958US12110305B2Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical useGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Daniel H. Byun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →